News
New listing of NOCTILUCA
10
The company NOCTILUCA S.A. was newly listed on the GPW Main Market on 16 December 2024.
NOCTILUCA S.A. is the 410th company listed on the Main Market and the eighth new listing on the Main Market in 2024.
Key information
|
company name |
NOCTILUCA S.A |
|
ticker/short name |
NCL/NOCTILUCA |
|
market (main/parallel) |
Main Market (transfer from NewConnect) |
|
seat |
Toruń |
|
companies listed on the regulated market |
410 |
|
new listings in 2024 |
8 |
|
transfers from NC in 2024 / in total |
7 transfers in 2024 / 99 in total |
|
NC new listing date |
12 April 2022 |
|
business sector |
New technology |
|
companies in the sector |
7 |
|
Polish/foreign (other listing markets) |
Polish |
|
core business |
Noctiluca is a technology company dedicated to the development of advanced compounds (high performance materials), a key component of OLED panels, i.e. displays (screens, TVs, smartphones, tablets, wearables, VR devices) and light sources (lamps). |
|
offering/sale |
No offering (transfer from NewConnect)
|
|
public offering value |
- |
|
reference price |
Closing price on NC as at 13 December 2024 |
|
company valuation* |
PLN 134,190,275 |
|
value of introduced instruments* |
PLN 134,190,275 |
|
% free float |
49.26 % |
|
free float value* |
PLN 66,098,150 |
|
% free float in all shares (below 5%) |
49.26 % |
|
free float value * in all shares |
PLN 66,098,150 |
|
number of shareholders |
Series A, B, C, D, E, G, H shares are currently traded in the NewConnect ATS so it is not possible to determine the total number of shareholders of the Company. |
|
Legal Advisor |
Schoenherr Halwa Okoń Chyb spółka komandytowa |
|
Auditor |
Primefields sp. z o.o. |
|
Investment Firm |
Q SECURITIES S.A. |
* based on the average price of the Company's shares in the NC ATS in the last 3 months preceding the date of the application for admission, i.e. PLN 84.85
Issuer’s history and business
Noctiluca S.A. was spun off from Synthex Technologies sp. z o.o. and now operates as a stand-alone entity with the mission of researching and developing proprietary technologies for the OLED market * and commercialising them with industry partners. The company was incorporated on 18 December 2018. Under the deed of incorporation, series A, series B and series C shares were subscribed for by investors. The company was established with the participation of financial investors: R Ventures I ASI Sp. z o.o., ASI Valuetech Seed Sp. z o.o., and Polski Instytut Badań i Rozwoju Inwestycje Sp. z o.o. (funds under the NCBR Bridge Alpha programme).
The issuer is a technology company engaged in the development of advanced chemical compounds used to produce next-generation displays and lighting. The chemical compounds that Noctiluca designs and synthesises are called emitters. These are organic compounds that, when excited by an electrical charge, emit light of a specific colour. This property has enabled the development of a modern display technology - OLED.
OLED emitters are in the form of a powder and are a key component of any OLED display. The powder is encapsulated inside a special diode. The diodes are used to create an OLED panel, then a matrix, and finally, with all these layers, a finished OLED display that emits the image viewed by the user.
The Company's business segments include:
- development and commercialisation of proprietary products in the form of advanced compounds (high performance materials), which are a key component of OLED panels, primarily OLED emitters - the Company's core business segment;
- contracted research projects implemented as a chemical contract research organisation (CRO) in the field of organic chemistry for applications in electronics;
- contracted synthesis services of organic compounds for electronic applications.
Issuer’s selected financials (PLN):
|
|
Q1-3 2024 |
2023 |
2022 |
2021 |
|
Net sales revenue and equivalent revenue incl.: - change of inventory |
995 293.43 59 000.33 |
754 029.95 -1 400 419.45 |
1 033 110.94 835 866.14 |
563 729.10 558 343.50 |
|
Net profit |
-5 136 920.28 |
-5 116 091.24 |
-2 855 934.40 |
-2 372 745.59 |
|
Total assets |
2 483 339.24 |
4 588 681.09 |
3 791 150.42 |
6 419 166.88 |
|
Equity |
472 440.96 |
3 305 361.24 |
1 982 252.48 |
4 833 405.27 |
|
Liabilities and provisions |
2 010 898.28 |
1 283 319.85 |
1 808 897.94 |
1 585 761.61 |
|
Total net cash flows |
-1 291 590.18 |
1 134 400.48 |
-3 163 272.99 |
733 113.77 |
|
Cash – closing balance |
755 873.51 |
2 032 875.03 |
912 712.87 |
4 075 956.40 |
Issuer’s shareholders
|
Shareholder |
# shares |
% of share capital |
# votes |
% of total vote |
|
Synthex Technologies sp. z o.o |
508,472 |
32.15% |
508,472 |
32.15% |
|
Mariusz Bosiak |
100,000 |
6.32% |
100,000 |
6.32% |
|
Polski Instytut Badań i Rozwoju Inwestycje ASI sp. z o.o |
97,014 |
6.13% |
97,014 |
6.13% |
|
ASI ValueTech Seed spółka |
97,014 |
6.13% |
97,014 |
6.13% |
|
Other |
779,000 |
49.26 |
779,000 |
49.26 |
|
Total |
1,581,500 |
100% |
1,581,500 |
100% |
Newly listed instruments:
- 743,472 series A ordinary bearer shares,
- 194,028 series B ordinary bearer shares,
- 62,500 series C ordinary bearer shares,
- 300,000 series D ordinary bearer shares,
- 80,000 series E ordinary bearer shares,
- 52,500 series G ordinary bearer shares,
- 125,000 series H ordinary bearer shares,
- 24,000 series I ordinary bearer shares.
